Maximilian J Schloss1, Michael Hilby1, Katrin Nitz1, Raquel Guillamat Prats1, Bartolo Ferraro1, Giovanna Leoni1, Oliver Soehnlein1, Thorsten Kessler1, Wenyan He1, Bruno Luckow1, Michael Horckmans1, Christian Weber1, Johan Duchene1, Sabine Steffens2. 1. From the Institute for Cardiovascular Prevention (IPEK) (M.J.S., M. Hilby, K.N., R.G.P., B.F., G.L., O.S., M. Horckmans, C.W., J.D., S.S.), and BioMedical Center, Walter-Brendel-Centre for Experimental Medicine (W.H.), Ludwig-Maximilians-University (LMU), Munich, Germany; Max Delbrueck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (K.N.); German Heart Center Munich, Technical University Munich (TUM), Germany (T.K.); Klinikum der Universität München, Medizinische Klinik und Poliklinik IV, Arbeitsgruppe Klinische Biochemie, Germany (B.L.); German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Germany (O.S., C.W., S.S.); Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden (O.S.); and Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands (C.W.). 2. From the Institute for Cardiovascular Prevention (IPEK) (M.J.S., M. Hilby, K.N., R.G.P., B.F., G.L., O.S., M. Horckmans, C.W., J.D., S.S.), and BioMedical Center, Walter-Brendel-Centre for Experimental Medicine (W.H.), Ludwig-Maximilians-University (LMU), Munich, Germany; Max Delbrueck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (K.N.); German Heart Center Munich, Technical University Munich (TUM), Germany (T.K.); Klinikum der Universität München, Medizinische Klinik und Poliklinik IV, Arbeitsgruppe Klinische Biochemie, Germany (B.L.); German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Germany (O.S., C.W., S.S.); Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden (O.S.); and Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands (C.W.). sabine.steffens@med.uni-muenchen.de.
Abstract
OBJECTIVE: Circadian regulation of neutrophil homeostasis affects myocardial infarction (MI) healing. It is unknown whether diurnal variations of monocyte counts exist in the heart and whether this affects their cardiac infiltration in response to MI. APPROACH AND RESULTS: Murine blood and organs were harvested at distinct times of day and analyzed by flow cytometry. Ly6Chigh monocyte surface expression levels of chemokine receptors (CCR) were ≈2-fold higher at the beginning of the active phase, Zeitgeber Time (ZT) 13 compared with ZT5. This was because of enhanced receptor surface expression at ZT13, whereas no significant changes in total cellular protein levels were found. Most blood Ly6Chigh monocytes were CCR2high, whereas only a minority was CCR1high and CCR5high. We also found diurnal changes of classical monocyte blood counts in humans, being higher in the evening, while exhibiting enhanced CCR2 surface expression in the morning. In support of monocyte oscillations between blood and tissue, murine cardiac Ly6Chigh monocyte counts were highest at ZT13, accompanied by an upregulation of cardiac CC chemokine ligand 2 mRNA. Mice subjected to MI at ZT13 had an even higher upregulation of CCR2 surface expression on circulating monocytes compared with noninfarcted mice and more elevated cardiac CC chemokine ligand 2 protein expression and more pronounced Ly6Chigh monocyte infiltration compared with ZT5-infarcted mice. Concomitantly, CCR2 antagonism only inhibited the excessive cardiac Ly6Chigh monocyte infiltration after ZT13 MI but not ZT5 MI. CONCLUSIONS: CCR2 surface expression on Ly6Chigh monocytes changes in a time-of-day-dependent manner, which crucially affects cardiac monocyte recruitment after an acute ischemic event.
OBJECTIVE: Circadian regulation of neutrophil homeostasis affects myocardial infarction (MI) healing. It is unknown whether diurnal variations of monocyte counts exist in the heart and whether this affects their cardiac infiltration in response to MI. APPROACH AND RESULTS:Murine blood and organs were harvested at distinct times of day and analyzed by flow cytometry. Ly6Chigh monocyte surface expression levels of chemokine receptors (CCR) were ≈2-fold higher at the beginning of the active phase, Zeitgeber Time (ZT) 13 compared with ZT5. This was because of enhanced receptor surface expression at ZT13, whereas no significant changes in total cellular protein levels were found. Most blood Ly6Chigh monocytes were CCR2high, whereas only a minority was CCR1high and CCR5high. We also found diurnal changes of classical monocyte blood counts in humans, being higher in the evening, while exhibiting enhanced CCR2 surface expression in the morning. In support of monocyte oscillations between blood and tissue, murine cardiac Ly6Chigh monocyte counts were highest at ZT13, accompanied by an upregulation of cardiac CC chemokine ligand 2 mRNA. Mice subjected to MI at ZT13 had an even higher upregulation of CCR2 surface expression on circulating monocytes compared with noninfarcted mice and more elevated cardiac CC chemokine ligand 2 protein expression and more pronounced Ly6Chigh monocyte infiltration compared with ZT5-infarcted mice. Concomitantly, CCR2 antagonism only inhibited the excessive cardiac Ly6Chigh monocyte infiltration after ZT13 MI but not ZT5 MI. CONCLUSIONS:CCR2 surface expression on Ly6Chigh monocytes changes in a time-of-day-dependent manner, which crucially affects cardiac monocyte recruitment after an acute ischemic event.
Authors: Merry L Lindsey; Keith R Brunt; Jonathan A Kirk; Petra Kleinbongard; John W Calvert; Lisandra E de Castro Brás; Kristine Y DeLeon-Pennell; Dominic P Del Re; Nikolaos G Frangogiannis; Stefan Frantz; Richard J Gumina; Ganesh V Halade; Steven P Jones; Rebecca H Ritchie; Francis G Spinale; Edward B Thorp; Crystal M Ripplinger; Zamaneh Kassiri Journal: Am J Physiol Heart Circ Physiol Date: 2021-10-08 Impact factor: 5.125
Authors: Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty Journal: Arterioscler Thromb Vasc Biol Date: 2018-10 Impact factor: 8.311
Authors: Cristine J Reitz; Faisal J Alibhai; Tarak N Khatua; Mina Rasouli; Byram W Bridle; Thomas P Burris; Tami A Martino Journal: Commun Biol Date: 2019-10-03